{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T04:50:02Z","timestamp":1758862202970},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,2,19]],"date-time":"2004-02-19T00:00:00Z","timestamp":1077148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,2,19]],"date-time":"2004-02-19T00:00:00Z","timestamp":1077148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2004,3,1]]},"DOI":"10.1038\/sj.cgt.7700658","type":"journal-article","created":{"date-parts":[[2004,2,19]],"date-time":"2004-02-19T08:13:04Z","timestamp":1077178384000},"page":"194-207","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy"],"prefix":"10.1038","volume":"11","author":[{"given":"Chi-Feng","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Yran","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dar-Shih","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dah-Shyong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,2,19]]},"reference":[{"key":"BF7700658_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW . Intracavitary Bacillus Calmette\u2013Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116:180\u2013183.","journal-title":"J Urol"},{"key":"BF7700658_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0022-5347(01)67606-7","volume":"153","author":"PD Vegt","year":"1995","unstructured":"Vegt PD, Witjes JA, Witjes WP, et al. A randomized study of intravesical mitomycin C, bacillus Calmette\u2013Guerin Tice and bacillus Calmette\u2013Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder. J Urol. 1995;153:929\u2013933.","journal-title":"J Urol"},{"key":"BF7700658_CR3","first-page":"499","volume":"19","author":"DL Lamm","year":"1992","unstructured":"Lamm DL . Carcinoma in situ. Urol Clin North Am. 1992;19:499\u2013508.","journal-title":"Urol Clin North Am"},{"key":"BF7700658_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s101470200042","volume":"7","author":"S Suzuki","year":"2002","unstructured":"Suzuki S, Shinohara N, Harabayashi T, et al. Complications of bacillus Calmette\u2013Guerin therapy in superficial urothelial cancer: clinical analysis and implications. Int J Clin Oncol. 2002;7:289\u2013293.","journal-title":"Int J Clin Oncol"},{"key":"BF7700658_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s002400050039","volume":"26","author":"JJ Patard","year":"1998","unstructured":"Patard JJ, Saint F, Velotti F, et al. Immune response following intravesical bacillus Calmette\u2013Guerin instillations in superficial bladder cancer: a review. Urol Res. 1998;26:155\u2013159.","journal-title":"Urol Res"},{"key":"BF7700658_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0022-5347(01)65748-3","volume":"156","author":"JL Chin","year":"1996","unstructured":"Chin JL, Kadhim SA, Batislam E, et al. Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer. J Urol. 1996;156:1189\u20131193.","journal-title":"J Urol"},{"key":"BF7700658_CR7","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/S0022-5347(05)65642-X","volume":"166","author":"A Morales","year":"2001","unstructured":"Morales A, Chin JL, Ramsey EW . Mycobacterial cell wall extract for treatment of carcinoma in situ of the bladder. J Urol. 2001;166:1633\u20131637.","journal-title":"J Urol"},{"key":"BF7700658_CR8","first-page":"1611","volume":"43","author":"A Shapiro","year":"1983","unstructured":"Shapiro A, Ratliff TL, Oakley DM, et al. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette\u2013Guerin and its correlation with Bacillus Calmette\u2013Guerin viability and natural killer cell activity. Cancer Res. 1983;43:1611\u20131615.","journal-title":"Cancer Res"},{"key":"BF7700658_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0022-5347(17)46976-X","volume":"134","author":"DR Kelley","year":"1985","unstructured":"Kelley DR, Ratliff TL, Catalona WJ, et al. Intravesical bacillus Calmette\u2013Guerin therapy for superficial bladder cancer: effect of bacillus Calmette\u2013Guerin viability on treatment results. J Urol. 1985;134:48\u201353.","journal-title":"J Urol"},{"key":"BF7700658_CR10","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0022-5347(17)35941-4","volume":"150","author":"A Bohle","year":"1993","unstructured":"Bohle A, Thanhauser A, Ulmer AJ, et al. Dissecting the immunobiological effects of Bacillus Calmette\u2013Guerin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon. J Urol. 1993;150:1932\u20131937.","journal-title":"J Urol"},{"key":"BF7700658_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0090-4295(96)00375-5","volume":"48","author":"P Stricker","year":"1996","unstructured":"Stricker P, Pryor K, Nicholson T, et al. Bacillus Calmette\u2013Guerin plus intravesical interferon alpha-2b in patients with superficial bladder cancer. Urology. 1996;48:957\u2013961.","journal-title":"Urology"},{"key":"BF7700658_CR12","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.4049\/jimmunol.162.4.2399","volume":"162","author":"Y Luo","year":"1999","unstructured":"Luo Y, Chen X, Downs TM, et al. IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette\u2013Guerin immunotherapy. J Immunol. 1999;162:2399\u20132405.","journal-title":"J Immunol"},{"key":"BF7700658_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0094-0143(05)70242-1","volume":"27","author":"SK Clinton","year":"2000","unstructured":"Clinton SK, Canto E, O'Donnell MA . Interleukin-12. Opportunities for the treatment of bladder cancer. Urol Clin North Am. 2000;27:147\u2013155.","journal-title":"Urol Clin North Am"},{"key":"BF7700658_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/003655902320131910","volume":"36","author":"NE Stavropoulos","year":"2002","unstructured":"Stavropoulos NE, Hastazeris K, Filiadis I, et al. Intravesical instillations of interferon in the prophylaxis of high risk superficial bladder cancer\u2013results of a controlled prospective study. Scand J Urol Nephrol. 2002;36:218\u2013222.","journal-title":"Scand J Urol Nephrol"},{"key":"BF7700658_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1055-3207(18)30447-2","volume":"4","author":"MA O'onnell","year":"1995","unstructured":"O'onnell MA, DeWolf WC . Bacillus Calmette\u2013Guerin immunotherapy for superficial bladder cancer. New prospects for an old warhorse. Surg Oncol Clin N Am. 1995;4:189\u2013202.","journal-title":"Surg Oncol Clin N Am"},{"key":"BF7700658_CR16","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","volume":"353","author":"AB Alexandroff","year":"1999","unstructured":"Alexandroff AB, Jackson AM, O\u2019onnell MA, et al. BCG immunotherapy of bladder cancer: 20 years on. Lancet. 1999;353:1689\u20131694.","journal-title":"Lancet"},{"key":"BF7700658_CR17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/1097-0215(20000915)87:6<844::AID-IJC14>3.0.CO;2-5","volume":"87","author":"AR Zlotta","year":"2000","unstructured":"Zlotta AR, Van Vooren JP, Denis O, et al. What are the immunologically active components of bacille Calmette\u2013-Guerin in therapy of superficial bladder cancer? Int J Cancer. 2000;87:844\u2013852.","journal-title":"Int J Cancer"},{"key":"BF7700658_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0022-5347(17)38290-3","volume":"145","author":"DL Lamm","year":"1991","unstructured":"Lamm DL, Riggs DR, DeHaven JI, et al. Immunotherapy of murine bladder cancer by irradiated tumor vaccine. J Urol. 1991;145:195\u2013198.","journal-title":"J Urol"},{"key":"BF7700658_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/ctrv.1998.0104","volume":"25","author":"S Nawrocki","year":"1999","unstructured":"Nawrocki S, Mackiewicz A . Genetically modified tumor cell vaccines\u2014where we are today. Cancer Treatment Rev. 1999;25:29\u201346.","journal-title":"Cancer Treatment Rev"},{"key":"BF7700658_CR20","first-page":"37","volume":"2","author":"S Brandau","year":"2001","unstructured":"Brandau S, Bohle A . Therapy of bladder cancer with BCG: the mechanism behind a successful immunotherapy. Mod Asp Immunobiol. 2001;2:37\u201341.","journal-title":"Mod Asp Immunobiol"},{"key":"BF7700658_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0958-1669(00)00215-9","volume":"12","author":"HA Smith","year":"2001","unstructured":"Smith HA, Klinman DM . The regulation of DNA vaccines. Curr Opin Biotechnol. 2001;12:299\u2013303.","journal-title":"Curr Opin Biotechnol"},{"key":"BF7700658_CR22","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","volume":"164","author":"G Widera","year":"2000","unstructured":"Widera G, Austin M, Rabussay D, et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol. 2000;164:4635\u20134640.","journal-title":"J Immunol"},{"key":"BF7700658_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1152\/jn.2000.83.1.343","volume":"83","author":"HL Wang","year":"2000","unstructured":"Wang HL, Tsai LY, Lee EH . Corticotropin-releasing factor produces a protein synthesis-dependent long-lasting potentiation in dentate gyrus neurons. J Neurophysiol. 2000;83:343\u2013349.","journal-title":"J Neurophysiol"},{"key":"BF7700658_CR24","first-page":"499","volume":"8","author":"M Morimura","year":"2001","unstructured":"Morimura M, Ishiko O, Sumi T, et al. Angiogenesis in adipose tissues and skeletal muscles with rebound weight-gain after diet-restriction in rabbits. Int J Mol Med. 2001;8:499\u2013503.","journal-title":"Int J Mol Med"},{"key":"BF7700658_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/jhep.2001.22002","volume":"33","author":"JS Gujral","year":"2001","unstructured":"Gujral JS, Bucci TJ, Farhood A, et al. Mechanism of cell death during warm hepatic ischemia\u2013reperfusion in rats: apoptosis or necrosis? Hepatology. 2001;33:397\u2013405.","journal-title":"Hepatology"},{"key":"BF7700658_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1128\/IAI.70.1.292-302.2002","volume":"70","author":"G Delogu","year":"2002","unstructured":"Delogu G, Li A, Repique C, et al. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis. Infect Immun. 2002;70:292\u2013302.","journal-title":"Infect Immun"},{"key":"BF7700658_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1006\/mthe.2002.0594","volume":"5","author":"SS Elliger","year":"2002","unstructured":"Elliger SS, Elliger CA, Lang C, et al. Enhanced secretion and uptake of -glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice. Mol Ther. 2002;5:617\u2013626.","journal-title":"Mol Ther"},{"key":"BF7700658_CR28","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1128\/IAI.67.8.4243-4250.1999","volume":"67","author":"M Velaz-Faircloth","year":"1999","unstructured":"Velaz-Faircloth M, Cobb AJ, Horstman AL, et al. Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein. Infect Immun. 1999;67:4243\u20134250.","journal-title":"Infect Immun"},{"key":"BF7700658_CR29","first-page":"5489","volume":"62","author":"M Kalat","year":"2002","unstructured":"Kalat M, Kupcu Z, Schuller S, et al. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model. Cancer Res. 2002;62:5489\u20135494.","journal-title":"Cancer Res"},{"key":"BF7700658_CR30","first-page":"81","volume":"10","author":"T Nishi","year":"1997","unstructured":"Nishi T, Dev SB, Yoshizato K, et al. Treatment of cancer using pulsed electric field in combination with chemotherapeutic agents or genes. Hum Cell. 1997;10:81\u201386.","journal-title":"Hum Cell"},{"key":"BF7700658_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nbt0298-168","volume":"16","author":"MP Rols","year":"1998","unstructured":"Rols MP, Delteil C, Golzio M, et al. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol. 1998;16:168\u2013171.","journal-title":"Nat Biotechnol"},{"key":"BF7700658_CR32","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/eji.1830250831","volume":"25","author":"S Cayeux","year":"1995","unstructured":"Cayeux S, Beck C, Aicher A, et al. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. Eur J Immunol. 1995;25:2325\u20132331.","journal-title":"Eur J Immunol"},{"key":"BF7700658_CR33","first-page":"1828","volume":"56","author":"H Wakimoto","year":"1996","unstructured":"Wakimoto H, Abe J, Tsunoda R, et al. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4. Cancer Res. 1996;56:1828\u20131833.","journal-title":"Cancer Res"},{"key":"BF7700658_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/sj.leu.2400598","volume":"11","author":"K Kato","year":"1997","unstructured":"Kato K, Okumura K, Yagita H . Immunoregulation by B7 and IL-12 gene transfer. Leukemia. 1997;11:572\u2013576.","journal-title":"Leukemia"},{"key":"BF7700658_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF01520291","volume":"40","author":"A Thanhauser","year":"1995","unstructured":"Thanhauser A, Bohle A, Schneider B, et al. The induction of bacillus-Calmette\u2013Guerin-activated killer cells requires the presence of monocytes and T-helper type-1 cells. Cancer Immunol Immunother. 1995;40:103\u2013108.","journal-title":"Cancer Immunol Immunother"},{"key":"BF7700658_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.cgt.7700330","volume":"8","author":"I Kuromatsu","year":"2001","unstructured":"Kuromatsu I, Matsuo K, Takamura S, et al. Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an antigen from mycobacteria. Cancer Gene Ther. 2001;8:483\u2013490.","journal-title":"Cancer Gene Ther"},{"key":"BF7700658_CR37","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.4049\/jimmunol.165.11.6463","volume":"165","author":"A Geluk","year":"2000","unstructured":"Geluk A, van Meijgaarden KE, Franken KL, et al. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol. 2000;165:6463\u20136471.","journal-title":"J Immunol"},{"key":"BF7700658_CR38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/30996","volume":"393","author":"SR Bennett","year":"1998","unstructured":"Bennett SR, Carbone FR, Karamalis F, et al. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature. 1998;393:478\u2013480.","journal-title":"Nature"},{"key":"BF7700658_CR39","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/30989","volume":"393","author":"JP Ridge","year":"1998","unstructured":"Ridge JP, Di Rosa F, Matzinger P . A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998;393:474\u2013478.","journal-title":"Nature"},{"key":"BF7700658_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0168-9525(00)89010-1","volume":"11","author":"SJ Korsmeyer","year":"1995","unstructured":"Korsmeyer SJ . Regulators of cell death. Trends Genet. 1995;11:101\u2013105.","journal-title":"Trends Genet"},{"key":"BF7700658_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1083\/jcb.124.1.1","volume":"124","author":"JC Reed","year":"1994","unstructured":"Reed JC . Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1\u20136.","journal-title":"J Cell Biol"},{"key":"BF7700658_CR42","first-page":"4263","volume":"62","author":"P Burke","year":"2002","unstructured":"Burke P, DeNardo SJ, Miers LA, et al. Cilengitide targeting of v 3 integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts. Cancer Res. 2002;62:4263\u20134272.","journal-title":"Cancer Res"},{"key":"BF7700658_CR43","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1136\/jcp.40.11.1314","volume":"40","author":"IA Cree","year":"1987","unstructured":"Cree IA, Nurbhai S, Milne G, et al. Cell death in granulomata: the role of apoptosis. J Clin Pathol. 1987;40:1314\u20131319.","journal-title":"J Clin Pathol"},{"key":"BF7700658_CR44","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1084\/jem.180.4.1499","volume":"180","author":"A Molloy","year":"1994","unstructured":"Molloy A, Laochumroonvorapong P, Kaplan G . Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette\u2013Guerin. J Exp Med. 1994;180:1499\u20131509.","journal-title":"J Exp Med"},{"key":"BF7700658_CR45","first-page":"414","volume":"59","author":"F Cavallo","year":"1999","unstructured":"Cavallo F, Di Carlo E, Butera M, et al. Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. Cancer Res. 1999;59:414\u2013421.","journal-title":"Cancer Res"},{"key":"BF7700658_CR46","first-page":"1005","volume":"61","author":"YI Yamashita","year":"2001","unstructured":"Yamashita YI, Shimada M, Hasegawa H, et al. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res. 2001;61:1005\u20131012.","journal-title":"Cancer Res"},{"key":"BF7700658_CR47","first-page":"3281","volume":"61","author":"F Lohr","year":"2001","unstructured":"Lohr F, Lo DY, Zaharoff DA, et al. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res. 2001;61:3281\u20133284.","journal-title":"Cancer Res"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7700658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700658","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:09:57Z","timestamp":1682640597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7700658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,19]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3,1]]}},"alternative-id":["BF7700658"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7700658","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,19]]},"assertion":[{"value":"15 April 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2004","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}